Contents

Inflammation & Allergy - Drug Targets (Discontinued), Volume 7 - Number 1

Mesalamine for Inflammatory Bowel Disease: Recent Reappraisals

, 7(1): 1 - 5

Giovanni C. Actis, Paola Pazienza and Floriano Rosina


DOI: 10.2174/187152808784165180




Liver Tolerance and the Manipulation of Immune Outcomes

, 7(1): 6 - 18

Lauren E. Holz, Geoffrey W. McCaughan, Volker Benseler, Patrick Bertolino and David G. Bowen


DOI: 10.2174/187152808784165225




Inflammatory Aspects of Depression

, 7(1): 19 - 23

Ubiratan C. Adler, Andrea H. Marques and Helena M. Calil


DOI: 10.2174/187152808784165216




Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders

, 7(1): 24 - 29

Giulia De Vivo, Antonio Martin, Tiziana Trotta and Vittorio Gentile


DOI: 10.2174/187152808784165171




Emerging Mucus Regulating Drugs in Inflammatory and Allergic Lung Disease

, 7(1): 30 - 34

Hans-Peter Hauber and Peter Zabel


DOI: 10.2174/187152808784165153




Selective Inhibitors of Nuclear Factor of Activated T Cells: Potential Therapeutic Drugs for the Treatment of Immunological and Inflammatory Diseases

, 7(1): 35 - 40

Osamu Kaminuma


DOI: 10.2174/187152808784165207




Transferrin and the Transferrin Receptor: Of Magic Bullets and Other Concerns

, 7(1): 41 - 52

Maria F. Macedo and Maria de Sousa


DOI: 10.2174/187152808784165162




Molecular Targets of Rheumatoid Arthritis

, 7(1): 53 - 66

Hiroshi Okamoto, Daisuke Hoshi, Akiko Kiire, Hisashi Yamanaka and Naoyuki Kamatani


DOI: 10.2174/187152808784165199




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science